Antithrombotic therapy after prosthetic cardiac valve implantation: improving postoperative, long-term patient management. Introduction.
Publication
, Journal Article
Berkowitz, SD
Published in: Am Heart J
May 2001
Duke Scholars
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
May 2001
Volume
141
Issue
5
Start / End Page
847 / 848
Location
United States
Related Subject Headings
- Time Factors
- Thrombosis
- Thrombolytic Therapy
- Postoperative Care
- Humans
- Heart Valves
- Heart Valve Prosthesis Implantation
- Heart Valve Diseases
- Fibrinolytic Agents
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Berkowitz, S. D. (2001). Antithrombotic therapy after prosthetic cardiac valve implantation: improving postoperative, long-term patient management. Introduction. Am Heart J, 141(5), 847–848. https://doi.org/10.1067/mhj.2001.114977
Berkowitz, S. D. “Antithrombotic therapy after prosthetic cardiac valve implantation: improving postoperative, long-term patient management. Introduction.” Am Heart J 141, no. 5 (May 2001): 847–48. https://doi.org/10.1067/mhj.2001.114977.
Berkowitz SD. Antithrombotic therapy after prosthetic cardiac valve implantation: improving postoperative, long-term patient management. Introduction. Am Heart J. 2001 May;141(5):847–8.
Berkowitz, S. D. “Antithrombotic therapy after prosthetic cardiac valve implantation: improving postoperative, long-term patient management. Introduction.” Am Heart J, vol. 141, no. 5, May 2001, pp. 847–48. Pubmed, doi:10.1067/mhj.2001.114977.
Berkowitz SD. Antithrombotic therapy after prosthetic cardiac valve implantation: improving postoperative, long-term patient management. Introduction. Am Heart J. 2001 May;141(5):847–848.
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
May 2001
Volume
141
Issue
5
Start / End Page
847 / 848
Location
United States
Related Subject Headings
- Time Factors
- Thrombosis
- Thrombolytic Therapy
- Postoperative Care
- Humans
- Heart Valves
- Heart Valve Prosthesis Implantation
- Heart Valve Diseases
- Fibrinolytic Agents
- Cardiovascular System & Hematology